Holen Sie sich die Stockscreener-App
19.57
3.08%
0.585
Schlusskurs vom Vortag:
$18.99
Offen:
$18.98
24-Stunden-Volumen:
74,124
Relative Volume:
0.93
Marktkapitalisierung:
$1.13B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-75.28M
KGV:
-9.8086
EPS:
-1.9957
Netto-Cashflow:
$-57.45M
1W Leistung:
+3.52%
1M Leistung:
+1.58%
6M Leistung:
+2.22%
1J Leistung:
+25.97%
1-Tages-Spanne:
$18.98
$19.84
1-Wochen-Bereich:
$18.64
$19.84
52-Wochen-Spanne:
$14.00
$23.08
Oculis Holding Ag Stock (OCS) Company Profile
Firmenname
Oculis Holding Ag
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie OCS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OCS
Oculis Holding Ag
|
19.57 | 1.10B | 0 | -75.28M | -57.45M | -1.9957 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Oculis Holding Ag Stock (OCS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-27 | Eingeleitet | Needham | Buy |
| 2023-12-05 | Eingeleitet | Chardan Capital Markets | Buy |
| 2023-10-05 | Eingeleitet | Stifel | Buy |
| 2023-06-14 | Eingeleitet | BofA Securities | Buy |
| 2023-06-12 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-06-08 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-05-10 | Eingeleitet | Pareto | Buy |
| 2023-04-28 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Oculis Holding Ag Aktie (OCS) Neueste Nachrichten
Will Oculis Holding AG stock benefit from commodity prices2025 Volume Leaders & Community Consensus Trade Signals - Newser
Is Oculis Holding’s New Equity Shelf Shaping a More Flexible Capital Strategy for OCS Investors? - simplywall.st
Oculis (NASDAQ:OCS) Coverage Initiated at Lifesci Capital - MarketBeat
How analysts revise price targets for Oculis Holding AG (CR5) stockMarket Movers & Low Drawdown Momentum Ideas - Newser
Why Oculis Holding AG (CR5) stock is upgraded to buyMarket Activity Report & Weekly Chart Analysis and Guides - Newser
How Oculis Holding AG Equity Warrant stock performs in interest rate cycles2025 Winners & Losers & Verified Swing Trading Watchlists - Newser
LifeSci Capital Initiates Coverage of Oculis Holding (OCS) with Outperform Recommendation - Nasdaq
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities - MarketScreener
Oculis Holding AG (OCS) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Liquidity Mapping Around (OCS) Price Events - news.stocktradersdaily.com
Why Oculis Holding AG stock could benefit from AI revolution2025 Major Catalysts & AI Driven Price Predictions - moha.gov.vn
Oculis (OCS) files transaction notice for director RSU vesting dated Nov. 25, 2025 - Stock Titan
US Market Recap: Can Oculis Holding AG stock deliver surprise earnings beatJuly 2025 Final Week & Reliable Entry Point Trade Alerts - moha.gov.vn
Can Oculis Holding AG stock deliver surprise earnings beat - BỘ NỘI VỤ
Is Oculis Holding AG Equity Warrant stock positioned well for digital economyTrade Entry Report & Smart Swing Trading Techniques - BỘ NỘI VỤ
How strong is Oculis Holding AG stock balance sheetQuarterly Trade Report & Entry Point Confirmation Signals - BỘ NỘI VỤ
Oculis reports Q3 EPS (32c), consensus (41c) - MSN
Oculis (NASDAQ: OCS) to Run Global PIONEER Privosegtor Trials in AON and NAION - Stock Titan
Analysts Set Oculis Holding AG (NASDAQ:OCS) Target Price at $39.80 - Defense World
Cash per share of Oculis Holding AG – FWB:CR5 - TradingView
Why (OCS) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
Will Oculis Holding AG stock keep outperforming rivalsTrade Exit Report & Consistent Profit Trading Strategies - newser.com
Why millennials buy Oculis Holding AG (CR5) stockJuly 2025 Outlook & Stock Portfolio Risk Management - newser.com
Is Oculis Holding AG Equity Warrant stock a good choice for value investorsWeekly Trade Recap & Real-Time Stock Movement Alerts - newser.com
Is Oculis Holding AG Equity Warrant stock oversold or undervaluedJuly 2025 Trends & Risk Controlled Daily Trade Plans - newser.com
What dividend safety score for Oculis Holding AG Equity Warrant stockPrice Action & Expert Curated Trade Ideas - newser.com
Exit strategy if you’re trapped in Oculis Holding AG Equity WarrantQuarterly Market Summary & AI Forecast for Swing Trade Picks - newser.com
Will Oculis Holding AG (CR5) stock hit Wall Street targets2025 Growth vs Value & Real-Time Volume Triggers - newser.com
Can Oculis Holding AG stock sustain market leadershipMarket Growth Report & Community Trade Idea Sharing - newser.com
What moving averages say about Oculis Holding AG2025 Top Decliners & Long-Term Safe Investment Plans - newser.com
Will Oculis Holding AG stock deliver shareholder valueQuarterly Portfolio Report & AI Enhanced Trade Execution Alerts - newser.com
Why Oculis Holding AG Equity Warrant stock remains resilientEarnings Recap Summary & High Conviction Buy Zone Alerts - newser.com
Oculis Holding AG Equity Warrant stock trend outlook and recovery pathMarket Risk Analysis & Risk Controlled Swing Alerts - newser.com
Oculis price target raised to $42 from $36 at H.C. Wainwright - MSN
Why analysts raise outlook for Oculis Holding AG (CR5) stockQuarterly Market Summary & Consistent Growth Stock Picks - newser.com
Visualizing Oculis Holding AG Equity Warrant stock with heatmapsDividend Hike & AI Driven Stock Reports - newser.com
Why retail investors favor Oculis Holding AG stock2025 Price Action Summary & Reliable Entry Point Trade Alerts - newser.com
Can Oculis Holding AG stock deliver strong Q4 earnings2025 Technical Overview & Advanced Technical Analysis Signals - newser.com
Finanzdaten der Oculis Holding Ag-Aktie (OCS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.10%
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):